Despite the existence of clinical phenotypic overlaps between MOG-associated disease (MOGAD), MS, and AQP4 antibody-associated NMOSD, cumulative biological, clinical, and pathological evidence discriminates between these conditions. Here, MOG is linked to myeloid sarcoma.